© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
June 27, 2021
Of the two diabetes treatments included in the study, patients with Gla-300 had lower recorded total health costs and greater commitment to treatment.
Researchers found a significant interaction between SGLT2 inhibitors based on age and eGFR.
June 26, 2021
Data show 37.5% of patients in study were found to have moderate to severe DD, with an average score of ≥2.
eGFR improved by 10.8% and creatinine decreased by 6.8% in patients who received PIT procedures.
Data show consistent benefit of finerenone on kidney and CV outcomes in patients with CKD and T2D, regardless of SGLT-2i use.
The COVID-19 pandemic has increased the usage of telemedicine tools in all medical fields.
Over half of patients attained target A1C
Overweight/obese patients with elevated fasting blood glucose generally present with higher degrees of insulin resistance, inflammation, adverse cardiovascular disease risk profile.
June 25, 2021
A comparison of 3 standard dietary strategies for weight and glycemia control showed no difference in exercise metrics.
The ADA study represents the first randomized head-to-head trial directly compareding an FRC with a remix insulin analog in a population of adults with suboptimally controlled type 2 diabetes on basal insulin plus OADs.